Сегодня во многих странах мира отмечается красивый весенний #праздн��к — День подснежника. В настоящее время #подснежники занесены в Красную Книгу как исчезающий вид. Не рвите эти #первоцветы и не покупайте! Помогите сохранить этот прекрасный #цветок для наших потомков! #��есна
We need to learn more from Netherlands on how they managed to be on track reaching #fasttrack 909090 targets with 89% tested 92% in treatment and 95% virally supressed @EECAAC_official@UNAIDS_EECA
80% of those starting #ARV treatment in Netherlands do so within one month of #HIV diagnosis according to Van Sighem Ard @EECAAC_official proving that reaching 909090 is possible.
GOALS and AEM presented by Keith Sabin at @EECAAC2018 shows great perspectives of projection for cost efficiency analyses for the national #AIDS response and allows for modelling of various scenarios based on different budgets and interventions. @Zohrabyanl
Keith Sabin presenting at #eecaac2018 the geostatistics model approach that proved to be very useful for shaping the #HIV and #AIDS services. @Zohrabyanl
Uzbekistan is monitoring the #ARV drug resistance since 2015 according to WHO protocol as presented by Evgheniya Kazakova from Virology Research Institute #EECAAC2018@Zohrabyanl
Analyses by Lev Zohrabyan at #EECAAC2018 shows age group 30-39 in #EECA registers the highest number of #HIV cases which if combined with CD4 results shows a late diagnosis in the region.
Kireev Dmitriy Rospotrebnadzor shared at #EECAAC2018 the importance of molecular epidemiology for #HIV surveillance, for example data showed that in the Soviet Union #HIV infection spread started in Odessa in 1984 with HIV1 A-FSU type. @Zohrabyanl
25 Сессия #ЕССААС 2018 профилактика ВИЧ инфекции среди молодёжи; Казахстанский опыт проведения дебатов для молодёжи про ВИЧ и СПИД@UNAIDS_EECA@EECAAC_official
Dr De Luca shared at #EECAAC2018 the #WHO recommendation on testing #ARV resistance before initiating #ARV#Treatment and pointed out that we will not reach viral supression in #T90T90T90 without pre-ART testing of drug resistance.